Durvalumab in Stage III Non-Small-Cell Lung Cancer
- PMID: 29490170
- DOI: 10.1056/NEJMc1716426
Durvalumab in Stage III Non-Small-Cell Lung Cancer
Comment on
-
Durvalumab in Stage III Non-Small-Cell Lung Cancer.N Engl J Med. 2018 Mar 1;378(9):868. doi: 10.1056/NEJMc1716426. N Engl J Med. 2018. PMID: 29504720 No abstract available.
-
Durvalumab in Stage III Non-Small-Cell Lung Cancer.N Engl J Med. 2018 Mar 1;378(9):869. doi: 10.1056/NEJMc1716426. N Engl J Med. 2018. PMID: 29504721 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical